persuading prescribers n.
Skip this Video
Loading SlideShow in 5 Seconds..
Persuading Prescribers PowerPoint Presentation
Download Presentation
Persuading Prescribers

Persuading Prescribers

148 Views Download Presentation
Download Presentation

Persuading Prescribers

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Persuading Prescribers Adriane Fugh-Berman MD Georgetown University Wilson Lectureship, Albuquerque September 29, 2006 (c) A. Fugh-Berman

  2. Drugs are important.. • But so is rational use • The most-promoted drugs are not necessarily the best • Drugs are not benign (c) A. Fugh-Berman

  3. Drug CostsAccording to the CDC… • Between 1997 and 2002 prescription drug expenses increased from 14% to 23% of total health care expenses • In 2002, average expenses for Rx drugs were about $1,100 per person (75% higher than 1997) • In 2002, average out-of-pocket expenses for prescription drugs were about 50% higher than in 1997 ( (c) A. Fugh-Berman

  4. Drug CostsAccording to the GAO… • Drug costs constitute 10.7% of health care expenditures • In 2004, spending for prescription drugs was $188.5 billion, almost five times what was spent in 1990 GAO. Price Trends for Frequently Used Brand and Generic Drugs from 2000 through 2004. (c) A. Fugh-Berman

  5. Kaiser Family Foundation • From 1994 to 2004, in the U.S. • Population grew 12% • Number of Rx purchased increased 68% • Retail Rx prices increased 8.3% annually • Inflation rate was 2.5% annually (c) A. Fugh-Berman

  6. Use of drugs by elders • More than 90% of persons ≥65 years old used a least one medication per week • More than 40% used at least 5 medications per week • 12% used at least 10 medications per week Kaufman DW. JAMA 2002;287:337 (c) A. Fugh-Berman

  7. “As use of medications grew between 1980 and 2000, the number of days Americans spent in the hospital fell by 56 percent, representing 206 million days of unneeded hospital care in 2000 alone. Although this study does not show that drugs caused the number of hospitalizations to fall, it is likely that they played a role.” PhRMA. Pharmaceutical Industry profile, 2006. PHRMA’s view… (c) A. Fugh-Berman

  8. ADR Frequency by Drug Use Frequency (%) 0-5 6-10 11-15 16-20 Number of Medications May FE. Clin Pharmacol Ther 1977;22:322-8. Slide courtesy of Karim Calis, NIH

  9. Promoting the profitable • There are more than 10,000 drugs in the US pharmaceutical market • More than half of promotional expenditures are concentrated on the top-selling 50 drugs Ma J et al. Clin Ther 2003;25(5):1503-17 (c) A. Fugh-Berman

  10. Promotion includes • Detailing • Advertising in journals • Meetings and events • E-detailing • Direct Mail • Publications • DTC advertising (c) A. Fugh-Berman

  11. Docs vs. Reality • Studies consistently show that promotion consistently increases prescribing of targeted drugs* • Studies consistently show that physicians do not believe that promotion affects prescribing** *Chren MM et al. JAMA 1994 Mar 2;271(9):684-9; Lurie N et al. J Gen Int Med 1990;5:240-243; Wazana A. JAMA 2000 Jan 19;283(3):373-80. **Sigworth SK et al. JAMA. 2001;286(9):1024-5.McKinney WP et al. JAMA 1990;264(13):1693-7. (c) A. Fugh-Berman

  12. The costs of promotion • In 2000, total promotion cost for Rx drugs was almost 16 billion dollars • About $5 billion spent on detailing • Sales force expenditures average $875 million per company (c) A. Fugh-Berman

  13. Detailing: In a poll of 2608 practicing physicians … • 9% said information provided by reps was “very accurate” • 72% said information was “somewhat accurate” • 14% said that it was “not very” or “not at all” accurate” • 15% found information provided by reps “very useful” • 59% found it “somewhat useful” Kaiser Family Foundation National Survey of Physicians, May 2002. (c) A. Fugh-Berman

  14. Detailing: A rep’s view An official job description for a pharmaceutical sales rep would read: Provide health-care professionals with product information, answer their questions on the use of products, and deliver product samples. An unofficial, and more accurate, description would have been: Change the prescribing habits of physicians. Reidy J. Hard Sell: the evolution of a Viagra salesman. Andrews McMeel Publishing, Kansas City: 2005 (c) A. Fugh-Berman

  15. What drug reps cost • Between 1995 and 2005, the number of drug reps in the US increased from 38,000 to 100,000 • Pharmaceutical companies spend $150,000 annually per primary care rep and $330,000 per specialty rep* • Average annual income for a drug rep is $81,700 ($62,400 plus $19,300 bonuses)** *Med Ad News 2004;23(3):1; ** Pharm Exec 2005 (January) (c) A. Fugh-Berman

  16. Meetings and events • Dinner meetings • Rounds • Symposia • CME (c) A. Fugh-Berman

  17. Meetings:Pharma controls CME • In 2004, more than half of the $2 billion dollars spent on CME came from pharmaceutical manufacturers • Medical Education and Communication Companies (MECs) launder money for pharma • 75% of their income is from firms that manufacture FDA-regulated products • Medical schools are just as bad • Pharma provides almost two thirds (63.8%) of CME income to medical schools (ACCME) (c) A. Fugh-Berman

  18. Some universities court Pharma • “CCOE and UMDNJ faculty can advise, assist and advocate to propose and position educational activities for product awareness, acceptance, and utilization” • Services include “Validation of scientific and promotional messages” UMDMJ Center for Continuing and Outreach Education (c) A. Fugh-Berman

  19. Advertising in medical journals • 5 of 6 physician organizations raised at least10% of annual revenue from advertising in affiliated medical journals • More than 95% of ads in JAMA are for Rx drugs • Pharma companies also purchase “sponsored” subscriptions • And are the largest purchaser of reprints Fugh-Berman A, Alladin K, Chow J. PLoS Medicine 2006;3(6):e130 (c) A. Fugh-Berman

  20. What about R&D costs? • Between 1970 and 2005, research and development accounted for between 8.5% and 17. 3% of sales(PhRMA Annual Membership survey 2006) • Pharma spends 3 times as much on marketing as it does on research (c) A. Fugh-Berman

  21. Physicians are not the only prescribers • Physician assistants and advanced practice nurses have not received much attention … • But will in the future (c) A. Fugh-Berman

  22. Conclusions • More rational prescribing, including increased use of older drugs with well-established benefits and risks, would reduce drug costs • Reducing inappropriate drug use will also decrease adverse effects and benefit our patients • Pharma should not participate in continuing education of health care practitioners (c) A. Fugh-Berman

  23. Recommended Books Abramson, John. Overdo$ed America Angell, Marcia. The truth about the drug companies Avorn, Jerry. Powerful medicines David, Healy. Let them eat Prozac David, Healy. The antidepressant era Elliott, Carl. Better than well Goozner, Merrill. The $800 million pill Kassirer, Jerome P. On the take Moynihan, Ray. Selling Sickness Mundy, Alicia. Dispensing with the truth Reidy, Jamie. Hard Sell Washburn, Jennifer. University, Inc

  24. Organizations • No Free Lunch • Healthy Skepticism • Health Care Renewal • GoozNews • PharmaWatch • Center for Science in the Public Interest Integrity in Science Project • American Medical Student Association • Health Action International • Consumers International

  25. • Coming soon! • Funded by the Attorney General Prescriber and Consumer Education Grant Program • We’ll provide news and resources, list pharma-free CME, and provide CME (and hopefully CE) modules on pharmaceutical promotion (c) A. Fugh-Berman